1. Home
  2. WVE vs EEX Comparison

WVE vs EEX Comparison

Compare WVE & EEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • EEX
  • Stock Information
  • Founded
  • WVE 2012
  • EEX 2013
  • Country
  • WVE Singapore
  • EEX United States
  • Employees
  • WVE N/A
  • EEX N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • EEX Advertising
  • Sector
  • WVE Health Care
  • EEX Consumer Discretionary
  • Exchange
  • WVE Nasdaq
  • EEX Nasdaq
  • Market Cap
  • WVE 915.6M
  • EEX 930.5M
  • IPO Year
  • WVE 2015
  • EEX 2017
  • Fundamental
  • Price
  • WVE $8.31
  • EEX $4.30
  • Analyst Decision
  • WVE Strong Buy
  • EEX Strong Buy
  • Analyst Count
  • WVE 14
  • EEX 1
  • Target Price
  • WVE $20.79
  • EEX $7.70
  • AVG Volume (30 Days)
  • WVE 3.6M
  • EEX 49.5K
  • Earning Date
  • WVE 11-07-2025
  • EEX 10-31-2025
  • Dividend Yield
  • WVE N/A
  • EEX 1.37%
  • EPS Growth
  • WVE N/A
  • EEX N/A
  • EPS
  • WVE N/A
  • EEX 0.02
  • Revenue
  • WVE $93,946,000.00
  • EEX $437,500,000.00
  • Revenue This Year
  • WVE N/A
  • EEX $17.23
  • Revenue Next Year
  • WVE $6.26
  • EEX $6.65
  • P/E Ratio
  • WVE N/A
  • EEX $215.82
  • Revenue Growth
  • WVE N/A
  • EEX 11.18
  • 52 Week Low
  • WVE $5.28
  • EEX $3.22
  • 52 Week High
  • WVE $16.74
  • EEX $5.45
  • Technical
  • Relative Strength Index (RSI)
  • WVE 56.37
  • EEX 26.53
  • Support Level
  • WVE $8.18
  • EEX $3.69
  • Resistance Level
  • WVE $9.75
  • EEX $4.92
  • Average True Range (ATR)
  • WVE 0.64
  • EEX 0.23
  • MACD
  • WVE 0.14
  • EEX -0.05
  • Stochastic Oscillator
  • WVE 48.94
  • EEX 42.75

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About EEX Emerald Holding Inc.

Emerald Holding Inc is a business-to-business (B2B) event organizer principally in the United States. The company is engaged in three complementary business lines; Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry; the Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division which offers software-as-a-service technology that enables year-round B2B buying and selling through Elastic Suite and Bulletin platforms for use by its customers. The Majority of the revenue for the company is generated from its Connections segment.

Share on Social Networks: